L. Wagner

Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women.

J. Lambert, M. McElrath, D. Francis, 1999, The Journal of infectious diseases.

Preventing discrimination against volunteers in prophylactic HIV vaccine trials: lessons from a phase II trial.

M. Keefer, P. Fast, M. Mcelrath, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Trial-related discrimination in HIV vaccine clinical trials.

M. Allen, H. Israel, S. Erb, 2001, AIDS research and human retroviruses.

Characteristics of volunteer participants in phase I HIV vaccine trials.

L. Wagner, G. K. Rybczyk, C. L. Crumbo, 1997, The Journal of the Association of Nurses in AIDS Care : JANAC.

Safety profile of phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation Group.

M. L. Clements-Mann, R. Belshe, B. Graham, 1997, AIDS research and human retroviruses.